Table 6.
Gene1 | Position of SNP | rs-number | Part of gene/predicted consequence | VAF/control2 | VAF/patients2 |
CLDN2 | c.-178-678C>G (g.29466911) | rs62605981 | Intron/5’ gene flanking region3 | 0.175 | 0.139 |
c.-178-104_-103delAT (g.29467485_29467486delAT) | rs72466477 | Intron/5’ gene flanking region3 | 0.175 | 0.083 |
The following reference sequences have been used for claudin (CLDN)2 NT_011651.16 (genomic) and NM_020384.2 (mRNA);
Variant allele frequencies (VAF) are defined with respect to the corresponding reference sequence;